Case number 2021-1078
Biogen International GmbH v. Amneal Pharmaceuticals LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 6, 2022 | 0 | BIOGEN INTERNATIONAL GMBH v. AMNEAL PHARMACEUTICALS LLC [ORDER] [nonprecedential] (0) |
| Oct 31, 2022 | 94 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [93] filed by Appellants Biogen MA, Inc. and Biogen International GmbH. The above-captioned appeals are dismissed.; denying as moot [86] any other pending motion. Each side shall bear its own costs.; issuing mandate; Service as of this date by the Clerk of Court. [881117] [21-1078, 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, 21-1098, 21-1441] [LMS] [Entered: 10/31/2022 10:48 AM] (3) |
| Oct 17, 2022 | 93 | MOTION of Appellants Biogen International GmbH and Biogen MA, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 10/17/2022 by email. [878478] [21-1078] [William Lee] [Entered: 10/17/2022 06:18 PM] (6) |
| May 31, 2022 | 92 | ORDER filed granting motion to stay [84] to the extent that the briefing schedule in the above-captioned appeals remains stayed.; holding in abeyance motion for summary affirmance [86] filed by Appellees. Within 14 days of the completion date specified above or the expiration of the time to seek certiorari if no such petition is filed, the parties are directed to inform the court how they believe these appeals should proceed. Service as of this date by the Clerk of Court. [852849] [LMS] [Entered: 05/31/2022 04:05 PM] (3) |
| May 4, 2022 | 91 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [88], ERROR: The case number is incomplete. CORRECTION: For future filings, please include all consolidated case numbers. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [847576] [EKD] [Entered: 05/04/2022 03:44 PM] (0) |
| May 4, 2022 | 90 | Notice from Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA, Inc. NOTICE OF WITHDRAWAL OF PETER M. KOHLHEPP AS COUNSEL FOR HETERO USA INC., HETERO LABS LIMITED, AND HETERO LABS LIMITED UNIT-III. Service: 05/04/2022 by email. [847498] [21-1078] [Saukshmya Trichi] [Entered: 05/04/2022 12:33 PM] (3) |
| May 4, 2022 | 89 | Notice from Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA, Inc. NOTICE OF WITHDRAWAL OF SAUKSHMYA TRICHI AS COUNSEL FOR HETERO USA INC., HETERO LABS LIMITED, AND HETERO LABS LIMITED UNIT-III. Service: 05/04/2022 by email. [847494] [21-1078] [Saukshmya Trichi] [Entered: 05/04/2022 12:31 PM] (3) |
| May 3, 2022 | 88 | Amended Entry of appearance for Todd S. Werner as counsel for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, and Hetero USA, Inc. Service: 05/03/2022 by email. [847178] [21-1078]--[Edited 05/04/2022 by EKD to correct filer] [Todd Werner] [Entered: 05/03/2022 01:26 PM] (1) |
| May 2, 2022 | 87 | RESPONSE of Appellants Biogen International GmbH and Biogen MA, Inc. to Doc No. [86]. Service: 05/02/2022 by email. [846873] [21-1078] [William Lee] [Entered: 05/02/2022 03:02 PM] (17) |
| Apr 20, 2022 | 86 | RESPONSE of Appellees Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Cipla Limited, Cipla USA Inc., Lupin Atlantis Holdings SA, MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Pharmathen S.A., Prinston Pharmaceutical Inc., S&B Pharma, Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Twi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc. and Zydus Pharmaceuticals (USA) Inc. to the status report motion to continue stay [84] filed by Appellants Biogen International GmbH and Biogen MA, Inc. with MOTION to for summary affirmance. Cases to be terminated: 21-1078; 21-1087; 21-1091; 21-1092; 21-1093; 21-1094; 21-1095; 21-1097; 21-1098; 21-1441. (Briefing suspended pursuant to FCR 31 pending resolution of the motion).. Service: 04/20/2022 by email [844446] [21-1078] [David Zimmer] [Entered: 04/20/2022 07:05 PM] (54) |
| Apr 6, 2022 | 85 | Defendants-Appellees' Joint Submission Explaining Why the Stay of These Appeals Should Not be Extended for Appellees Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Cipla Limited, Cipla USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA, Inc., Lupin Atlantis Holdings SA, MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Pharmathen S.A., S&B Pharma, Inc., Sandoz Inc., Shilpa Medicare Limited, Twi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc. and Prinston Pharmaceutical Inc.. Service: 04/06/2022 by email. [841515] [21-1078] [William Zimmerman] [Entered: 04/06/2022 08:52 PM] (6) |
| Apr 6, 2022 | 84 | Status Report for Appellants Biogen International GmbH and Biogen MA, Inc. with MOTION to continue stay of proceedings. Service: 04/06/2022 by email. [841509] [21-1078] [William Lee] [Entered: 04/06/2022 08:15 PM] (14) |
| Apr 6, 2022 | 83 | Notice from Appellee Amneal Pharmaceuticals LLC Defendant-Appellee's Notice of Withdrawal of Samuel Sherry as Counsel. Service: 04/06/2022 by email. [841487] [21-1078] [David Zimmer] [Entered: 04/06/2022 05:21 PM] (4) |
| Dec 14, 2021 | 82 | Docketing Statement for the Appellees Twi Pharmaceuticals USA, Inc. and TWi Pharmaceuticals, Inc.. Service: 12/14/2021 by email. [818587] [21-1078] [Philip Segrest] [Entered: 12/14/2021 03:11 PM] (6) |
| Dec 14, 2021 | 81 | ORDER granting motions [79] [80] to the extent that TWi’s certificate of interest and entry of appearance are accepted and the official caption is revised to reflect TWi’s participation. The revised official caption is reflected in the order. TWi’s docketing statement is due no later than seven days from the date of filing of this order. [NL] [Entered: 12/14/2021 10:35 AM] (3) |
| Dec 6, 2021 | 80 | Certificate of Interest for TWi Pharmaceuticals Inc.; TWi Pharmaceuticals USA, Inc.. Service: 12/06/2021 by email. [816359] [21-1078] [Philip Segrest] [Entered: 12/06/2021 11:45 AM] (5) |
| Dec 6, 2021 | 79 | Entry of appearance for Don J. Mizerk; Philip D. Segrest, Jr. as counsel for TWi Pharmaceuticals Inc.; TWi Pharmaceuticals USA, Inc.. Service: 12/06/2021 by email. [816357] [21-1078] [Philip Segrest] [Entered: 12/06/2021 11:44 AM] (1) |
| Nov 17, 2021 | 78 | ORDER filed. The motion [77] is granted to the extent that Ms. Rurka is withdrawn as counsel for Prinston, and Shashank Upadhye’s entry of appearance as principal counsel is accepted for filing. Service as of this date by the Clerk of Court. [813134] [NL] [Entered: 11/17/2021 02:09 PM] (3) |
| Nov 12, 2021 | 77 | MOTION of Appellee Prinston Pharmaceutical Inc. to withdraw counsel Maureen L. Rurka. Service: 11/12/2021 by email. [811994] [21-1078] [Maureen Rurka] [Entered: 11/12/2021 05:04 PM] (8) |
| Nov 12, 2021 | 76 | Entry of appearance for Shashank Upadhye as counsel for Appellee Prinston Pharmaceutical Inc.. Service: 11/12/2021 by email. [811984] [21-1078] [Shashank Upadhye] [Entered: 11/12/2021 04:41 PM] (1) |
| Apr 19, 2021 | 75 | ORDER filed granting motion [66] to the extent that the briefing schedule in the above-captioned appeals remains stayed. Within 14 days of the issuance of mandate in Appeal No. 2020-1933, the parties are directed to inform the court how they believe these appeals should proceed. The Clerk of Court shall forward a copy of this order to the merits panel assigned to Appeal No. 2020-1933. Service as of this date by the Clerk of Court. [769663] [LMS] [Entered: 04/19/2021 04:28 PM] (3) |
| Apr 16, 2021 | 74 | Docketing Statement for the Appellees Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc.. Service: 04/16/2021 by email. [769414] [21-1078] [Stephen Benson] [Entered: 04/16/2021 06:26 PM] (3) |
| Apr 16, 2021 | 73 | Certificate of Interest for Appellees Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc.. Service: 04/16/2021 by email. [769413] [21-1078] [Stephen Benson] [Entered: 04/16/2021 06:25 PM] (4) |
| Apr 16, 2021 | 72 | Entry of appearance for Stephen P. Benson as counsel for Appellees Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc.. Service: 04/16/2021 by email. [769412] [21-1078] [Stephen Benson] [Entered: 04/16/2021 06:23 PM] (1) |
| Apr 15, 2021 | 71 | Notice to Appellees Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, and Sun Pharmaceutical Industries, Inc.: The record of this case indicates that no compliant Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [768907] [EKD] [Entered: 04/15/2021 01:55 PM] (0) |
| Mar 30, 2021 | 70 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, and Sun Pharmaceutical Industries, Inc., Entry of Appearance [67], is not in compliance with the rules of this court (see attached). Compliant document is due on 04/06/2021. Service as of this date by the Clerk of Court. [765660] [EKD] [Entered: 03/30/2021 02:25 PM] (1) |
| Mar 30, 2021 | 69 | ORDER granting motion to extend time to file brief [68] to the extent that the briefing schedule is stayed pending the court's consideration of the motion to hold these appeals in abeyance. Service as of this date by the Clerk of Court. [765619] [LMS] [Entered: 03/30/2021 12:31 PM] (3) |
| Mar 29, 2021 | 68 | MOTION of Appellees Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Cipla Limited, Cipla USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., Lupin Atlantis Holdings SA, MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Pharmathen S.A., Prinston Pharmaceutical Inc., S&B Pharma, Inc., Sandoz Inc., Shilpa Medicare Limited, Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. and Zydus Pharmaceuticals (USA) Inc. to extend the time to 04/19/2021 to file brief. Service: 03/29/2021 by email. [765507] [21-1078] [David Zimmer] [Entered: 03/29/2021 06:38 PM] (45) |
| Mar 26, 2021 | 67 | Entry of appearance for Stephen P. Benson as counsel for Appellees Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc.. Service: 03/26/2021 by email. [764988] [21-1078] This document is non-compliant. See Doc No. [70] [Stephen Benson] [Entered: 03/26/2021 12:24 PM] (1) |
| Mar 25, 2021 | 66 | MOTION of Appellees Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Cipla Limited, Cipla USA Inc., Hetero Labs Limited, Hetero USA Inc., Lupin Atlantis Holdings SA, MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Pharmathen S.A., Prinston Pharmaceutical Inc., S&B Pharma, Inc., Sandoz Inc., Shilpa Medicare Limited, Sun Pharma Global FZE, Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. and Zydus Pharmaceuticals (USA) Inc. To Hold Case in Abeyance Pending This Court's Decision In Biogen Int'l GmbH v. Mylan Pharmaceuticals Inc. , No. 20-1933. Service: 03/25/2021 by email. [764835] [21-1078] [David Zimmer] [Entered: 03/25/2021 06:48 PM] (47) |
| Feb 22, 2021 | 65 | MODIFIED ENTRY: BRIEF FILED by Appellants Biogen International GmbH and Biogen MA Inc. Service: 02/22/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [757735] --[Edited 02/24/2021 by EKD - compliance review complete] [William Lee] [Entered: 02/22/2021 04:35 PM] (87) |
| Feb 22, 2021 | 64 | Amended Certificate of Interest for Appellants Biogen International GmbH and Biogen MA Inc.. Service: 02/22/2021 by email. [757733] [21-1078] [William Lee] [Entered: 02/22/2021 04:34 PM] (4) |
| Feb 9, 2021 | 63 | **TEXT ONLY** ORDER granting motion to withdraw attorney William G. McElwain [62] filed by Appellants Biogen MA Inc. and Biogen International GmbH. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [754834] [EKD] [Entered: 02/09/2021 02:46 PM] (0) |
| Feb 9, 2021 | 62 | MOTION of Appellants Biogen International GmbH and Biogen MA Inc. to withdraw counsel William G. McElwain. Service: 02/09/2021 by email. [754720] [21-1078] [Thomas Saunders] [Entered: 02/09/2021 09:51 AM] (6) |
| Jan 8, 2021 | 61 | Official caption revised due to non-participation of parties (see attached). Service as of this date by the Clerk of Court. [748005] [JAL] [Entered: 01/08/2021 11:07 AM] (2) |
| Jan 8, 2021 | 60 | Note to File: The following cases are consolidated: 21-1078 Lead with 21-1441 Consolidated Member Case. The parties must file all documents in the lead appeal only. [747983] [21-1078, 21-1441] [EKD] [Entered: 01/08/2021 10:18 AM] (0) |
| Jan 8, 2021 | 59 | ORDER consolidating appeals 21-1078 with 21-1441. The opening brief for the consolidated appeals is due February 22, 2021. Service as of this date by the Clerk of Court. [747980] [21-1078, 21-1441] [EKD] [Entered: 01/08/2021 10:14 AM] (2) |
| Jan 5, 2021 | 58 | Amended Certificate of Interest for Appellants Biogen International GmbH and Biogen MA Inc.. Service: 01/05/2021 by email. [747076] [21-1078] [William Lee] [Entered: 01/05/2021 04:43 PM] (4) |
| Dec 22, 2020 | 57 | Corrected Entry of appearance for Saukshmya Trichi as counsel for Appellee Shilpa Medicare Limited. Service: 12/22/2020 by email. [744905] [21-1078] [Todd Werner] [Entered: 12/22/2020 05:27 PM] (1) |
| Dec 22, 2020 | 56 | Corrected Entry of appearance for Saukshmya Trichi as counsel for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc.. Service: 12/22/2020 by email. [744894] [21-1078] [Todd Werner] [Entered: 12/22/2020 05:04 PM] (1) |
| Dec 22, 2020 | 55 | Docketing Statement for the Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc. and Shilpa Medicare Limited. Service: 12/22/2020 by email. [744727] [21-1078] [Todd Werner] [Entered: 12/22/2020 01:26 PM] (4) |
| Dec 22, 2020 | 54 | Corrected Certificate of Interest for Appellee Shilpa Medicare Limited. Service: 12/22/2020 by email. [744723] [21-1078] [Todd Werner] [Entered: 12/22/2020 01:21 PM] (4) |
| Dec 22, 2020 | 53 | Corrected Certificate of Interest for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc.. Service: 12/22/2020 by email. [744719] [21-1078] [Saukshmya Trichi] [Entered: 12/22/2020 01:12 PM] (4) |
| Dec 18, 2020 | 52 | ORDER granting motion to extend time to file brief [49]. The opening brief is due 02/04/2021. Service as of this date by the Clerk of Court. [743936] [NL] [Entered: 12/18/2020 03:15 PM] (2) |
| Dec 17, 2020 | 51 | Notice from Appellees Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-III and Shilpa Medicare Limited Entry of Appearance for Saukshmya Trichi. Service: 12/17/2020 by email. [743488] [21-1078] [Saukshmya Trichi] [Entered: 12/17/2020 01:11 PM] (3) |
| Dec 16, 2020 | 50 | NOTICE OF NON-COMPLIANCE: The submissions of Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., and Shilpa Medicare Limited, Certificates of Interest [46], [48], are not in compliance with the rules of this court (see attached). Compliant document is due on 12/23/2020. Service as of this date by the Clerk of Court. [743057] [EKD] [Entered: 12/16/2020 08:45 AM] (1) |
| Dec 14, 2020 | 49 | MOTION of Appellants Biogen International GmbH and Biogen MA Inc. to extend the time to 02/04/2021 to file brief. Service: 12/14/2020 by email. [742508] [21-1078] [William Lee] [Entered: 12/14/2020 03:01 PM] (9) |
| Dec 8, 2020 | 48 | Certificate of Interest for Appellee Shilpa Medicare Limited. Service: 12/08/2020 by email. [741192] [21-1078] This document is non-compliant. See Doc No. [50] [Todd Werner] [Entered: 12/08/2020 03:50 PM] (4) |
| Dec 8, 2020 | 47 | Entry of appearance for Todd S. Werner; Peter M. Kohlhepp as counsel for Appellee Shilpa Medicare Limited. Service: 12/08/2020 by email. [741188] [21-1078] [Todd Werner] [Entered: 12/08/2020 03:48 PM] (1) |
| Dec 8, 2020 | 46 | Certificate of Interest for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc.. Service: 12/08/2020 by email. [741182] [21-1078] This document is non-compliant. See Doc No. [50] [Todd Werner] [Entered: 12/08/2020 03:43 PM] (4) |
| Dec 8, 2020 | 45 | Entry of appearance for Todd S. Werner; Peter M. Kohlhepp as counsel for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc.. Service: 12/08/2020 by email. [741178] [21-1078] [Todd Werner] [Entered: 12/08/2020 03:40 PM] (1) |
| Dec 4, 2020 | 44 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [41], ERROR: The document contains a non-compliant signature. CORRECTION: For future filings, please use an electronic signature consisting of the printed name of the individual preceded by the mark /s/ entered on the signature line. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [740443] [EKD] [Entered: 12/04/2020 04:15 PM] (0) |
| Dec 4, 2020 | 43 | Docketing Statement for the Appellee Pharmathen S.A.. Service: 12/04/2020 by email. [740306] [21-1078] [H. Sabharwal] [Entered: 12/04/2020 11:53 AM] (4) |
| Dec 3, 2020 | 42 | Docketing Statement for the Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 12/03/2020 by email. [740187] [21-1078] [Jonathan Turpin] [Entered: 12/03/2020 09:12 PM] (4) |
| Dec 3, 2020 | 41 | Docketing Statement for the Appellees MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sandoz Inc. and Prinston Pharmaceutical Inc.. Service: 12/03/2020 by email. [740001] [21-1078] [Maureen Rurka] [Entered: 12/03/2020 01:40 PM] (4) |
| Dec 2, 2020 | 40 | Notice to Appellees Accord Healthcare Inc., Graviti Pharmaceuticals Inc., Graviti Pharmaceuticals Pvt. Ltd., Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., Impax Laboratories LLC, Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Shilpa Medicare Limited, Slayback Pharma India LLP, Slayback Pharma LLC, TWi Pharmaceuticals Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Twi Pharmaceuticals USA, Inc., and Windlas Healthcare Pvt. Ltd.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b) has been filed. The record of this case indicates that no Certificate of Interest under FCR 47.4 has been filed. The record of this case indicates that no Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in adverse action. See FCR 25(h). Service as of this date by the Clerk of Court. [739757] [EKD] [Entered: 12/02/2020 04:31 PM] (0) |
| Dec 2, 2020 | 39 | Notice to Appellees MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Pharmathen S.A., Prinston Pharmaceutical Inc., Sandoz Inc., and Zydus Pharmaceuticals (USA) Inc.: The record of this case indicates that no Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in adverse action. See FCR 25(h). Service as of this date by the Clerk of Court. [739747] [EKD] [Entered: 12/02/2020 04:24 PM] (0) |
| Nov 24, 2020 | 38 | Corrected Certificate of Interest for Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc.. Service: 11/24/2020 by email. [738061] [21-1078] [George Barry] [Entered: 11/24/2020 01:48 PM] (5) |
| Nov 19, 2020 | 37 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc., Certificate of Interest [34], is not in compliance with the rules of this court (see attached). Compliant document is due on 11/30/2020. Service as of this date by the Clerk of Court. [736979] [EKD] [Entered: 11/19/2020 01:53 PM] (1) |
| Nov 18, 2020 | 36 | Entry of appearance for Timothy H. Kratz; George J. Barry III as counsel for Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc.. Service: 11/18/2020 by email. [736709] [21-1078] [George Barry] [Entered: 11/18/2020 03:05 PM] (1) |
| Nov 18, 2020 | 35 | Docketing Statement for the Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc.. Service: 11/18/2020 by email. [736706] [21-1078] [George Barry] [Entered: 11/18/2020 03:03 PM] (4) |
| Nov 18, 2020 | 34 | Certificate of Interest for Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc. Service: 11/18/2020 by email. [736705] [21-1078] This document is non-compliant. See Doc No. [37] [George Barry] [Entered: 11/18/2020 03:02 PM] (5) |
| Nov 9, 2020 | 33 | Corrected Docketing Statement for the Appellees Cipla Limited and Cipla USA Inc.. Service: 11/09/2020 by email. [734597] [21-1078] [William Zimmerman] [Entered: 11/09/2020 07:26 PM] (4) |
| Nov 9, 2020 | 32 | Corrected Certificate of Interest for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/09/2020 by email. [734596] [21-1078] [William Zimmerman] [Entered: 11/09/2020 07:24 PM] (6) |
| Nov 9, 2020 | 31 | Corrected Entry of appearance for William R. Zimmerman, principal counsel; Thomas P. Krzeminski, of cousel; Joseph M. Reisman, of counsel as counsel for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/09/2020 by email. [734595] [21-1078] [William Zimmerman] [Entered: 11/09/2020 07:21 PM] (2) |
| Nov 9, 2020 | 30 | Certificate of Interest for Appellees Sandoz Inc. and Prinston Pharmaceutical Inc.. Service: 11/09/2020 by email. [734515] [21-1078] [Maureen Rurka] [Entered: 11/09/2020 02:37 PM] (4) |
| Nov 6, 2020 | 29 | NOTICE OF NON-COMPLIANCE: The submissions of Appellees Cipla Limited and Cipla USA Inc. Entry of Appearance, and Appellees Prinston Pharmaceutical Inc. and Sandoz Inc. Certificates of Interest [9], [15], [17], are not in compliance with the rules of this court (see attached). Compliant documents are due on 11/16/2020. Service as of this date by the Clerk of Court. [734206] [EKD] [Entered: 11/06/2020 12:11 PM] (2) |
| Nov 6, 2020 | 28 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [12], Doc No. [13], Doc No. [14], Doc No. [16], Doc No. [21], Doc No. [22], ERROR: The case number on the document is incomplete. CORRECTION: For future filings, please include all consolidated case numbers. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [734203] [EKD] [Entered: 11/06/2020 12:06 PM] (0) |
| Nov 6, 2020 | 27 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [7], Doc No. [8], Doc No. [10], Doc No. [11], Doc No. [23], Doc No. [24], Doc No. [25], ERROR: The case number on the document is incomplete. The caption provided on the document does not follow the official caption provided by the Clerk. Please refrain from using "et al." CORRECTION: For future filings, please include all consolidated case numbers. For future filings, see Docket Entry #2 for the caption. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [734200] [EKD] [Entered: 11/06/2020 12:03 PM] (0) |
| Nov 5, 2020 | 26 | Entry of appearance for James B. Monroe; Paul W. Browning; J. Michael Jakes; Jason L. Romrell as counsel for Appellants Biogen MA Inc. and Biogen International GmbH. Service: 11/05/2020 by email. [734052] [21-1078] [James Monroe] [Entered: 11/05/2020 07:05 PM] (2) |
| Nov 5, 2020 | 25 | Certificate of Interest for Appellee Amneal Pharmaceuticals LLC. Service: 11/05/2020 by email. [733853] [21-1078] [David Zimmer] [Entered: 11/05/2020 11:36 AM] (3) |
| Nov 5, 2020 | 24 | Docketing Statement for the Appellee Amneal Pharmaceuticals LLC. Service: 11/05/2020 by email. [733852] [21-1078] [David Zimmer] [Entered: 11/05/2020 11:33 AM] (2) |
| Nov 5, 2020 | 23 | Entry of appearance for David J. Zimmer; Huiya Wu; Samuel E. Sherry as counsel for Appellee Amneal Pharmaceuticals LLC. Service: 11/05/2020 by email. [733851] [21-1078] [David Zimmer] [Entered: 11/05/2020 11:28 AM] (2) |
| Nov 4, 2020 | 22 | Certificate of Interest for Appellee Pharmathen S.A.. Service: 11/04/2020 by email. [733743] [21-1078] [Yun Wei] [Entered: 11/04/2020 11:32 PM] (4) |
| Nov 4, 2020 | 21 | Entry of appearance for H. Keeto Sabharwal; Yun Wei as counsel for Appellee Pharmathen S.A.. Service: 11/04/2020 by email. [733742] [21-1078] [Yun Wei] [Entered: 11/04/2020 11:30 PM] (1) |
| Nov 4, 2020 | 20 | Docketing Statement for the Appellee Lupin Atlantis Holdings SA. Service: 11/04/2020 by email. [733734] [21-1078] [Imron Aly] [Entered: 11/04/2020 06:29 PM] (2) |
| Nov 4, 2020 | 19 | Certificate of Interest for Appellee Lupin Atlantis Holdings SA. Service: 11/04/2020 by email. [733733] [21-1078] [Imron Aly] [Entered: 11/04/2020 06:27 PM] (3) |
| Nov 4, 2020 | 18 | Entry of appearance for Imron T. Aly as counsel for Appellee Lupin Atlantis Holdings SA. Service: 11/04/2020 by email. [733732] [21-1078] [Imron Aly] [Entered: 11/04/2020 06:26 PM] (2) |
| Nov 4, 2020 | 17 | Certificate of Interest for Appellee Sandoz Inc.. Service: 11/04/2020 by email. [733729] [21-1078] This document is non-compliant. See Doc No. [29] [Maureen Rurka] [Entered: 11/04/2020 05:45 PM] (4) |
| Nov 4, 2020 | 16 | Entry of appearance for Maureen L. Rurka as counsel for Appellee Sandoz Inc.. Service: 11/04/2020 by email. [733728] [21-1078] [Maureen Rurka] [Entered: 11/04/2020 05:43 PM] (1) |
| Nov 4, 2020 | 15 | Certificate of Interest for Appellee Prinston Pharmaceutical Inc.. Service: 11/04/2020 by email. [733727] [21-1078] This document is non-compliant. See Doc No. [29] [Maureen Rurka] [Entered: 11/04/2020 05:41 PM] (4) |
| Nov 4, 2020 | 14 | Entry of appearance for Maureen L. Rurka as counsel for Appellee Prinston Pharmaceutical Inc.. Service: 11/04/2020 by email. [733725] [21-1078] [Maureen Rurka] [Entered: 11/04/2020 05:39 PM] (1) |
| Nov 4, 2020 | 13 | Certificate of Interest for Appellees MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.. Service: 11/04/2020 by email. [733723] [21-1078] [John McNair] [Entered: 11/04/2020 05:35 PM] (4) |
| Nov 4, 2020 | 12 | Entry of appearance for George Lombardi; John R. McNair; Jovial Wong; Maureen L. Rurka as counsel for Appellees MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.. Service: 11/04/2020 by email. [733722] [21-1078] [John McNair] [Entered: 11/04/2020 05:33 PM] (2) |
| Nov 4, 2020 | 11 | Certificate of Interest for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/04/2020 by email. [733717] [21-1078] [William Zimmerman] [Entered: 11/04/2020 05:28 PM] (6) |
| Nov 4, 2020 | 10 | Docketing Statement for the Appellees Cipla Limited and Cipla USA Inc.. Service: 11/04/2020 by email. [733716] [21-1078] [William Zimmerman] [Entered: 11/04/2020 05:26 PM] (4) |
| Nov 4, 2020 | 9 | Entry of appearance for William R. Zimmerman, principal counsel; Thomas P. Krzeminski, of counsel; Joseph M. Reisman, of counsel as counsel for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/04/2020 by email. [733713] [21-1078] This document is non-compliant. See Doc No. [29] [William Zimmerman] [Entered: 11/04/2020 05:24 PM] (2) |
| Nov 4, 2020 | 8 | Certificate of Interest for Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 11/04/2020 by email. [733676] [21-1078] [Jonathan Turpin] [Entered: 11/04/2020 03:48 PM] (3) |
| Nov 4, 2020 | 7 | Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; David B. Abramowitz; Timothy F. Peterson; Jonathan B. Turpin as counsel for Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 11/04/2020 by email. [733670] [21-1078] [Jonathan Turpin] [Entered: 11/04/2020 03:32 PM] (2) |
| Nov 4, 2020 | 6 | Docketing Statement for the Appellants Biogen International GmbH and Biogen MA Inc.. Service: 11/04/2020 by email. [733640] [21-1078] [William Lee] [Entered: 11/04/2020 02:10 PM] (2) |
| Nov 4, 2020 | 5 | Certificate of Interest for Appellants Biogen International GmbH and Biogen MA Inc.. Service: 11/04/2020 by email. [733638] [21-1078] [William Lee] [Entered: 11/04/2020 02:09 PM] (4) |
| Nov 4, 2020 | 4 | Entry of appearance for William F. Lee; William G. McElwain; Lisa J. Pirozzolo; Thomas G. Saunders; Madeleine C. Laupheimer; Annaleigh E. Curtis; Scott G. Greene as counsel for Appellants Biogen International GmbH and Biogen MA Inc.. Service: 11/04/2020 by email. [733635] [21-1078] [William Lee] [Entered: 11/04/2020 02:07 PM] (2) |
| Oct 23, 2020 | 3 | Note to File: The following cases are consolidated: 21-1078 Lead with 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, and 21-1098 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [731161] [21-1078, 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, 21-1098] [EKD] [Entered: 10/23/2020 04:09 PM] (0) |
| Oct 23, 2020 | 2 | ORDER consolidating appeals 21-1078, 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, and 21-1098. The opening brief for the consolidated appeals is due within 60 days from issuance of this order. Service as of this date by the Clerk of Court. [731158] [21-1078, 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, 21-1098] [EKD] [Entered: 10/23/2020 04:03 PM] (2) |
| Oct 21, 2020 | 1 | Appeal docketed. Received: 10/20/2020. [730610]Entry of Appearance is due on 11/04/2020. Certificate of Interest is due on 11/04/2020. Docketing Statement is due on 11/04/2020. Appellants' brief is due on 12/21/2020. [EKD] [Entered: 10/21/2020 02:50 PM] (72) |
